Jade Biosciences, Inc. Preferred Stock Convertible Shares Issuable
Jade Biosciences, Inc. (JBIO) had Preferred Stock Convertible Shares Issuable of 12.62 million shares as of 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Notes › Class of Stock Disclosures
us-gaap:PreferredStockConvertibleSharesIssuable · last filed 2025-11-14
- 2025-09-30: Preferred Stock Convertible Shares Issuable 12.62M shares.
- 2025-06-30: Preferred Stock Convertible Shares Issuable 12.62M shares.
| Period end | Preferred Stock Convertible Shares Issuable |
|---|---|
| 2025-09-30 | 12.62M shares 10-Q · filed 2025-11-14 |
| 2025-06-30 | 12.62M shares 10-Q · filed 2025-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |